AKTX Akari Therapeutics Plc - American Depositary Shares
$7.55
Price · Aug 24, 2026
Fundamentals as of Aug 13, 2026
52W Range
$0–$29
25% of range
Analyst Rating
BUY
10 analysts
Price Target
$28
+277% upside
P/E (TTM)
—
ROE
-64.1%
Net Profit Margin
—
AKTX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$7.55
Market Cap
$683.61B
P/E (TTM)
—
EPS (TTM)
$0.00
Revenue (TTM)
—
Div Yield
—
ROE
-64.1%
Debt/Equity
0.0
52W Range
$0 – $29
AKTX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Configure
10-Year Performance Revenue, net income, margins and EPS trends
Revenue & Net Income
—
EPS
$0.00
2022-12-31
→
2025-12-31
Free Cash Flow
—
2014-12-31
→
2015-12-31
Margins
—
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
Metric
5Y trend
AKTX
Peer Median
P/B
24131.9
0.9
EV / EBITDA
-39572.1
—
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Metric
5Y trend
AKTX
Peer Median
ROA
-35.1%
-74.6%
ROE
-64.1%
-92.1%
ROIC
-57.5%
—
Financial Health Debt, liquidity, solvency — balance sheet strength
Metric
5Y trend
AKTX
Peer Median
Debt / Equity
0.0
0.0
Current Ratio
0.4
2.7
Quick Ratio
0.0
—
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Metric
5Y trend
AKTX
Peer Median
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Metric
5Y trend
AKTX
Peer Median
AKTX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
BUY
10 analysts
- Strong Buy 3 30.0%
- Buy 6 60.0%
- Hold 1 10.0%
- Sell 0 0.0%
- Strong Sell 0 0.0%
12-Month Price Target
2 analysts · 2026-08-22
Median
$28.50
← Below all targets
$7.55
Low
$27.00
High
$30.00
Median target
$28.50
+277.5%
Mean target
$28.50
+277.5%
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
1.1%
| Period | EPS Actual | EPS Est | Surprise |
|---|---|---|---|
| March 31, 2026 | $-1.57 | $-1.40 | -0.17% |
| Dec. 31, 2025 | $0.00 | $-1.53 | 1.5% |
| Sept. 30, 2025 | $0.00 | $-3.13 | 3.1% |
| June 30, 2025 | $0.00 | $-4.69 | 4.7% |
| March 31, 2021 | $0.00 | $0.00 | 0.00% |
| March 31, 2020 | $-2.60 | $0.00 | -2.6% |
Peer comparison (GICS sub-industry) Key metrics vs sector peers
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| AKTX | $26.17B | — | — | — | -64.1% | — |
| BCDA | $13M | — | -87.8% | — | 1660.5% | — |
| PASG | $38M | -0.8 | — | — | -159.7% | — |
| PHIO | $12M | -0.2 | — | — | -57.5% | — |
| GTBP | $20M | -0.1 | — | — | -645.4% | — |
| LSTA | — | -1.0 | -83.0% | — | — | — |
| PDSB | — | -1.0 | — | — | — | — |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement 15
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $3M | $7M | $5M | $10M | $6M | $2M | $1M | |
| SG&A Expense | $9M | $10M | $11M | $14M | $6M | $303.1K | $2M | |
| Operating Expenses | $17M | $22M | $17M | · | $31M | $2M | · | |
| Operating Income | $-17M | $-22M | $-17M | $-23M | $-31M | $-2M | $-4M | |
| Interest Expense | $100.0K | · | · | · | $3M | $5.4K | · | |
| Interest Income | $1.0K | $8.0K | $82.0K | $46.0K | $20.7K | $91 | · | |
| Other Non-op | $-1M | $2M | $-19.0K | $-142.0K | $-15M | $-28.3K | $-14.0K | |
| Pretax Income | $-18M | $-20M | $-10M | $-17.7K | $-45M | $-2M | · | |
| Income Tax | $-1M | · | $0 | · | $0 | $0 | · | |
| Net Income | $-17M | $-20M | $-10M | $-18M | $-45M | $-2M | $-4M | |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | |
| Shares (Basic) | 67,328,128,638 | 23,888,010,485 | 9,788,980,193 | 6,243,462,410 | 852,088,530 | 85,515,588 | 21,075,065 | |
| Shares (Diluted) | 67,328,128,638 | 23,888,010,485 | 9,788,980,193 | 6,243,462,410 | 852,088,530 | 85,515,588 | 21,075,065 | |
| EBITDA | $-17M | $-22M | $-17M | · | $-31M | $-10M | · |
Balance Sheet 24
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $5M | $0 | $4M | $13M | $69M | $3M | $553.7K | |
| Prepaid Expense | $185.0K | $92.0K | $299.0K | $465.0K | $728.1K | $7.8K | · | |
| Other Current Assets | $14.0K | $201.0K | $197.0K | $100.0K | · | · | · | |
| Current Assets | $5M | $3M | $4M | $14M | $70M | $3M | $8M | |
| PP&E (Net) | · | · | · | · | $40.5K | $0 | $0 | |
| PP&E (Gross) | · | · | · | · | · | $67.0K | $10.0K | |
| Goodwill | $8M | $8M | · | · | · | · | · | |
| Intangibles | · | · | $14.0K | $17.0K | $52.5K | $59.4K | · | |
| Total Assets | $48M | $51M | $4M | $14M | $70M | $3M | $8M | |
| Accounts Payable | $9M | $12M | $2M | $947.0K | $4M | $555.5K | · | |
| Accrued Liabilities | $2M | $3M | $2M | $3M | $408.2K | $43.0K | $403.0K | |
| Short-term Debt | $81.0K | $659.0K | · | · | · | · | · | |
| Current Liabilities | $12M | $20M | $5M | · | $21M | $1M | $1M | |
| Deferred Tax | $7M | $8M | · | · | · | · | · | |
| Other Non-current Liabilities | $31.0K | $383.0K | · | · | · | $33.0K | $0 | |
| Total Liabilities | $20M | $28M | $5M | $12M | $21M | $1M | · | |
| Total Debt | $81.0K | $659.0K | · | · | · | · | · | |
| Common Stock | · | $5M | $1M | $745.0K | $18M | $11M | $675.0K | |
| Paid-in Capital | $234M | $213M | · | · | · | · | · | |
| Retained Earnings | $-265M | $-247M | $-227M | $-217M | $-57M | $-11M | $-21M | |
| AOCI | $-782.0K | $-738.0K | $-1M | $-771.0K | $156.5K | $46.1K | $-33.4K | |
| Stockholders' Equity | $28M | $22M | $-229.0K | $2M | $49M | $2M | $400.7K | |
| Liabilities + Equity | $48M | $51M | $4M | $14M | $70M | $3M | $8M | |
| Shares Outstanding | 90,536,879,533 | 53,186,919,523 | 13,234,315,298 | 7,444,917,123 | 1,177,693,383 | 722,345,600 | 40,227,953 |
Cash Flow 14
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| D&A | · | $14.0K | $4.0K | $4.0K | · | · | · | |
| Stock-based Comp | $3M | $2M | $1M | $735.0K | $1M | $0 | $94.0K | |
| Deferred Tax | $-1M | · | · | · | · | · | · | |
| Restructuring | $-50.0K | $2M | · | · | · | · | · | |
| Other Non-cash | · | $5M | $-8M | · | · | · | · | |
| Operating Cash Flow | $-11M | $-13M | $-16M | $-22M | $-5M | $-1M | $-5M | |
| CapEx | · | · | · | · | $10.6K | $0 | $0 | |
| Investing Cash Flow | · | $382.0K | · | · | $1M | $0 | $0 | |
| Stock Issued | $11M | $12M | $7M | $25M | $75M | $4M | $0 | |
| Net Stock Activity | $11M | $12M | $7M | · | $75M | $0 | · | |
| Financing Cash Flow | $13M | $11M | $7M | $25M | $69M | $4M | $12M | |
| Net Change in Cash | $3M | $-1M | $-9M | $4M | $66M | $3M | $7M | |
| Free Cash Flow | · | · | · | · | $-5M | $-10M | · | |
| Levered FCF | · | · | · | · | $-8M | · | · |
Profitability 3
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| ROA | -35.1% | -72.1% | -110.1% | · | -123.7% | -134.8% | · | |
| ROE | -64.1% | -254.8% | 125100.0% | · | -177.9% | -126.4% | · | |
| ROIC | -57.5% | -94.6% | 7338.9% | · | -62.8% | · | · |
Liquidity & Solvency 4
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.4 | 0.1 | · | · | 3.3 | 4.7 | · | |
| Quick Ratio | 0.0 | 0.1 | · | · | 3.3 | 4.6 | · | |
| Debt / Equity | 0.0 | 0.0 | · | · | · | · | · | |
| Interest Coverage | -172.8 | · | · | · | -10.0 | · | · |
Valuation (TTM) 9
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-17M | $-20M | $-10M | · | $-45M | $-2M | · | |
| Market Cap | $26.17B | $64.89B | $41.29B | · | $341.53B | $53.41B | · | |
| Enterprise Value | $26.17B | $64.89B | · | · | · | · | · | |
| P/B | 923.6 | 2919.1 | -180310.3 | · | 7010.1 | 11005.7 | · | |
| P / Tangible Book | 1315.0 | 4702.4 | · | · | · | · | · | |
| P / Cash Flow | -2475.9 | -5169.5 | -2512.8 | · | -68779.7 | -5645.4 | · | |
| P / FCF | · | · | · | · | -68633.7 | -5611.6 | · | |
| EV / EBITDA | -1514.6 | -3000.0 | · | · | · | · | · | |
| Earnings Yield | 0.00% | 0.00% | 0.00% | · | · | · | · |
Income Statement 15
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $2M | $1M | $1M | $249.0K | $667.0K | $813.0K | $1M | $143.0K | $3M | $2M | $3M | $1M | $3M | $1M | $142.0K | $2M | |
| SG&A Expense | $3M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $4M | $3M | $2M | $1M | $3M | $1M | $99.7K | |
| Operating Expenses | · | $16M | · | · | · | $4M | · | · | · | $6M | · | $4M | $4M | $23M | · | $2M | |
| Operating Income | $-5M | $-16M | $-3M | $-7M | $-3M | $-4M | $-5M | $-3M | $-7M | $-6M | $-5M | $-4M | $-4M | $-23M | $-1M | $-2M | |
| Interest Expense | · | · | $0 | $100.0K | · | · | · | · | $51.0K | · | · | $0 | $-6.0K | $3M | · | $4.6K | |
| Interest Income | · | · | $0 | $1.0K | · | · | $1.0K | $3.0K | $2.0K | $2.0K | $7.0K | $30.8K | $19.3K | $1.4K | · | $0 | |
| Other Non-op | $-205.0K | $444.0K | $-2M | $-84.0K | $1M | $-180.0K | $2M | $32.0K | $-109.0K | $-2.0K | $27.0K | $866.6K | $11M | $-25M | $-215.0K | $-42.2K | |
| Pretax Income | $-5M | $-15M | $-5M | $-7M | $-2M | $-4M | $-4M | $-3M | · | · | · | $-3M | $7M | $-49M | $-2M | $-2M | |
| Income Tax | · | $-859.0K | $85.0K | $-1M | · | · | · | · | · | $0 | · | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-5M | $-14M | $-5M | $-6M | $-2M | $-4M | $-4M | $-3M | $-8M | $-6M | $-4M | $-3M | $7M | $-49M | $-2M | $-2M | |
| EPS (Basic) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | |
| EPS (Diluted) | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | · | · | · | · | · | |
| Shares (Basic) | 143,317,469,445 | 118,757,013,401 | -115,530,287,566 | 65,326,236,698 | 62,943,895,665 | 54,588,283,841 | -32,787,621,994 | 24,386,005,523 | 18,836,478,977 | 13,453,147,979 | -17,917,475,885 | 1,177,693,383 | 109,727,643 | 781,738,789 | · | 722,345,600 | |
| Shares (Diluted) | 143,317,469,445 | 118,757,013,401 | -115,530,287,566 | 65,326,236,698 | 62,943,895,665 | 54,588,283,841 | -32,787,621,994 | 24,386,005,523 | 18,836,478,977 | 13,453,147,979 | -18,016,471,589 | 1,177,693,383 | 109,727,643 | 781,738,789 | · | 722,345,600 | |
| EBITDA | $-5M | $-16M | · | $-7M | $-3M | $-4M | · | $-3M | $-7M | $-6M | · | $-4M | · | $-23M | $-1M | $-2M |
Balance Sheet 23
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $8M | $3M | $0 | $2M | $3M | $3M | $0 | $2M | $4M | $1M | $4M | $61M | $69M | $79M | $3M | $4M | |
| Prepaid Expense | $532.0K | $731.0K | $185.0K | $349.0K | $447.0K | $627.0K | $92.0K | $396.0K | $805.0K | $1M | $299.0K | $1M | $728.1K | · | · | · | |
| Other Current Assets | $38.0K | $30.0K | $14.0K | $53.0K | $83.0K | $80.0K | $201.0K | $92.0K | $94.0K | $232.0K | $197.0K | · | · | · | · | · | |
| Current Assets | $8M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $5M | $3M | $4M | $63M | $70M | $79M | $3M | $4M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | $74.8K | $40.5K | $34.9K | $40.0K | $44.0K | |
| Goodwill | · | · | $8M | $8M | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | · | · | · | · | · | · | · | · | $14.0K | $49.0K | $52.5K | $58.1K | · | · | |
| Total Assets | $39M | $34M | $48M | $45M | $51M | $51M | $51M | $3M | $5M | $3M | $4M | $63M | $70M | $79M | $3M | $4M | |
| Accounts Payable | $9M | $9M | $9M | $11M | $12M | $13M | $12M | $5M | $5M | $3M | $2M | $625.4K | $4M | $4M | · | · | |
| Accrued Liabilities | $4M | $3M | $2M | $2M | $2M | $3M | $3M | $3M | $2M | $2M | $2M | $231.9K | $408.2K | $4M | · | · | |
| Short-term Debt | · | $49.0K | $81.0K | $198.0K | $179.0K | $228.0K | $659.0K | $200.0K | $600.0K | $900.0K | · | · | · | · | · | · | |
| Current Liabilities | $14M | $13M | $12M | $16M | $17M | $21M | $20M | $9M | $9M | $6M | $5M | $17M | $21M | $38M | $960.0K | $910.0K | |
| Deferred Tax | $6M | $6M | $7M | $7M | $8M | $8M | $8M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | $31.0K | $69.0K | $128.0K | $266.0K | $383.0K | · | · | · | · | · | · | · | $43.0K | $38.0K | |
| Total Liabilities | $20M | $20M | $20M | $23M | $25M | $29M | $28M | · | · | · | $5M | $17M | $21M | $38M | · | · | |
| Total Debt | · | $49.0K | · | $198.0K | $179.0K | $228.0K | · | $200.0K | $600.0K | $900.0K | · | · | · | · | · | · | |
| Common Stock | $1.0K | · | · | $7M | $7M | $6M | $5M | $2M | $2M | $2M | $1M | $18M | $18M | $18M | $927.0K | $927.0K | |
| Paid-in Capital | $244M | $235M | $234M | $224M | $221M | · | $213M | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-284M | $-279M | $-265M | $-259M | $-253M | $-251M | $-247M | $-243M | $-241M | $-233M | $-227M | $-60M | $-57M | $-63M | $-34M | $-33M | |
| AOCI | $-695.0K | $-768.0K | $-782.0K | $-1M | $-1M | $-773.0K | $-738.0K | $-926.0K | $-749.0K | $-761.0K | $-1M | $-36.5K | $156.5K | $197.1K | · | · | |
| Stockholders' Equity | $19M | $14M | $28M | $23M | $26M | $22M | $22M | $-7M | $-4M | $-4M | $-229.0K | $46M | $49M | $41M | $973.0K | $3M | |
| Liabilities + Equity | $39M | $34M | $48M | $45M | $51M | $51M | $51M | $3M | $5M | $3M | $4M | $63M | $70M | $79M | $3M | $4M | |
| Shares Outstanding | 140,032,769,533 | 91,567,009,533 | 90,536,879,533 | 65,229,461,523 | 65,229,461,523 | 57,752,981,523 | 53,186,919,523 | 24,289,231,523 | 24,289,232,698 | 15,973,121,298 | 13,234,315,298 | 1,177,693,383 | 1,177,693,383 | 1,177,693,383 | 55,636,283 | 55,636,283 |
Cash Flow 14
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | $1.0K | $0 | $0 | $13.0K | $1.0K | · | · | · | · | · | |
| Stock-based Comp | $711.0K | $305.0K | $471.0K | $685.0K | $719.0K | $1M | $1M | $248.0K | $445.0K | $296.0K | $304.0K | $816.8K | $963.8K | $-31.9K | $49.0K | $0 | |
| Deferred Tax | $0 | $-859.0K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Restructuring | · | · | $-100.0K | $0 | $100.0K | $-50.0K | $3M | $-3M | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | $1M | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-3M | $-2M | $-3M | $-2M | $-2M | $-1M | $-5M | $-4M | $-4M | $-7M | $-7M | $5M | $-1M | $-2M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | $42.1K | · | · | · | $0 | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $-42.1K | $-18.8K | $1M | $0 | $0 | |
| Stock Issued | · | · | $5M | $0 | $4M | $1M | $3M | $-133.0K | $7M | $2M | $4M | · | $0 | · | · | · | |
| Net Stock Activity | · | · | · | · | · | $2M | · | · | · | $2M | · | · | · | · | · | · | |
| Financing Cash Flow | $8M | $53.0K | $6M | $2M | $3M | $2M | $2M | $-443.0K | $8M | $2M | $4M | · | $-3M | $72M | $0 | $0 | |
| Net Change in Cash | $5M | $-2M | $3M | $-227.0K | $129.0K | $-17.0K | $413.0K | $-2M | $3M | $-3M | $-886.0K | $-7M | $-10M | $79M | $-1M | $-2M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | · | · | $-7M | · | · | · | · |
Profitability 3
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -10.7% | -34.1% | · | -26.6% | -6.8% | -13.8% | · | -7.1% | -188.1% | -16.9% | · | -8.9% | · | -123.1% | -112.9% | -107.3% | |
| ROE | -21.8% | -80.0% | · | -80.0% | -17.3% | -40.7% | · | -16.7% | 553.7% | -26.0% | · | -12.2% | · | -235.8% | -343.5% | -178.6% | |
| ROIC | · | -103.1% | · | -27.7% | · | · | · | · | · | · | · | -8.3% | · | -56.4% | -149.6% | -72.7% |
Liquidity & Solvency 4
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.6 | 0.3 | · | 0.2 | 0.2 | 0.2 | · | 0.3 | 0.6 | 0.4 | · | 3.8 | · | 2.1 | 3.0 | 4.7 | |
| Quick Ratio | 0.6 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.2 | 0.5 | 0.2 | · | 3.7 | · | 2.1 | 2.8 | 4.4 | |
| Debt / Equity | · | 0.0 | · | 0.0 | 0.0 | 0.0 | · | -0.0 | -0.2 | -0.3 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -74.0 | · | · | · | · | -146.1 | · | · | · | · | -7.6 | · | · |
Valuation (TTM) 9
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-28M | $-26M | · | $-15M | $-16M | $-20M | · | $-19M | $-20M | $-11M | · | $-55M | · | $-52M | $-6M | $-6M | |
| Market Cap | $1.43T | $471.57B | · | $65.88B | $76.32B | $71.61B | · | $71.65B | $65.58B | $29.79B | · | $329.75B | · | $565.18B | $6.45B | $8.46B | |
| Enterprise Value | · | $471.57B | · | $65.88B | $76.32B | $71.61B | · | $71.65B | $65.58B | $29.79B | · | · | · | · | · | · | |
| P/B | 77151.7 | 32793.5 | · | 2903.9 | 2980.6 | 3293.2 | · | -10704.1 | -17710.2 | -8384.4 | · | 7113.2 | · | 13674.2 | 6632.9 | 3258.8 | |
| P / Tangible Book | 77151.7 | 32793.5 | · | 4621.0 | 4443.6 | 5378.0 | · | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | · | -189537.8 | · | · | · | -33308.7 | · | · | · | -7366.4 | · | -44318.4 | · | · | · | -3844.0 | |
| P / FCF | · | · | · | · | · | · | · | · | · | · | · | -44069.1 | · | · | · | · | |
| EV / EBITDA | · | -29925.6 | · | -8897.8 | -24468.1 | -20315.3 | · | -24479.4 | -8803.5 | -4984.8 | · | · | · | · | · | · | |
| Earnings Yield | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | 0.00% | 0.00% | 0.00% | · | · | · | · | · | · |
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Income Statement
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|
| Net Income | $-17M | $-20M | $-10M | $-18M | $-45M |
| Diluted EPS | $0.00 | $0.00 | $0.00 | $0.00 | — |
Balance Sheet
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|
| Debt / Equity | 0.0 | 0.0 | — | — | — |
| Current Ratio | 0.4 | 0.1 | — | — | 3.3 |
| Quick Ratio | 0.0 | 0.1 | — | — | 3.3 |
Cash Flow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2015-12-31 | |
|---|---|---|---|---|---|
| Free Cash Flow | — | — | — | — | $-5M |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
📊
Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Institutional owners (13F) 1 filer · $6K total · As of Dec. 31, 2025
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Skyview Financial Group LLC | $5,946 | 20,575 | 100.00% | Shares |
Company insiders 24 insiders · 9 officers · 19 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Abizer Gaslightwala | CEO | June 24, 2026 A | 277,574 | 2 | 0 | $433,060 |
| Rachelle Suzanne Jacques | Chief Executive Officer | April 26, 2024 A | 1,018,027,792 | 0 | 0 | $0 |
| Gur Roshwalb | Chief Executive Officer | Sept. 21, 2015 A | — | 0 | 0 | $0 |
| Kameel D. Farag | Interim CFO | Aug. 17, 2026 A | 23,309 | 1 | 0 | $9,898 |
| Torsten Hombeck | CFO | March 20, 2025 A | 200 | 0 | 0 | $0 |
| Wendy F Dicicco | Interim CFO | May 1, 2024 A | 158,473,915 | 0 | 0 | $0 |
| Dov Elefant | Chief Financial Officer | Sept. 21, 2015 A | — | 0 | 0 | $0 |
| Clive Richardson | COO | Sept. 21, 2015 A | — | 0 | 0 | $0 |
| Robert M Shaw | General Counsel and Secretary | March 23, 2016 A | — | 0 | 0 | $0 |
| Samir R. Patel | Director | July 7, 2026 M | 98,241 | 2 | 0 | $340,262 |
| Sandip I Patel | Director | Dec. 16, 2025 P | 496,499 | 2 | 0 | $160,851 |
| Ray Prudo, M.D. | Director | Dec. 16, 2025 P | 2,484,990 | 2 | 0 | $402,127 |
| Robert B Bazemore | Director | Dec. 16, 2025 P | 44,642 | 2 | 0 | $61,865 |
| James R Neal | Director | Dec. 16, 2025 P | 36,271 | 2 | 0 | $2,226 |
| Hoyoung Huh | Director | Dec. 16, 2025 P | 4,695,854 | 2 | 0 | $1,484,780 |
| Mohamed Wa'El Ahmed Hashad | Director | June 28, 2024 A | — | 0 | 0 | $0 |
| Michael Grissinger | Director | June 28, 2024 A | — | 0 | 0 | $0 |
| Donald A Williams | Director | June 28, 2024 A | — | 0 | 0 | $0 |
| David Byrne | Director | June 29, 2016 A | — | 0 | 0 | $0 |
| Stuart Ungar | Director | June 29, 2016 A | — | 0 | 0 | $0 |
| James Hill | Director | June 29, 2016 A | — | 0 | 0 | $0 |
| Mark S Cohen | Director | June 29, 2016 A | 1,055,600 | 0 | 0 | $0 |
| Donald Allen Williams | Director | June 29, 2016 A | — | 0 | 0 | $0 |
| Allan Shaw | Director | Nov. 25, 2015 A | — | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Samir R. Patel | March 4, 2026 | 10.40% | Amendment | — | SEC |
| Ray Prudo, M.D., RPC Pharma Limited, Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company ×7 filings | March 4, 2026 | 0.87% | Amendment | — | SEC |
| Samir R. Patel (2) ×2 filings | Dec. 6, 2024 | — | Initial filing | — | SEC |
| Undisclosed reporting person | June 18, 2024 | — | Initial filing | — | SEC |
| Praxis Trustees Limited As trustee of The Sonic Healthcare Holding Company, RPC Pharma Limited, Ray Prudo, M.D. | Oct. 18, 2021 | — | Initial filing | — | SEC |
| RPC Pharma Limited, Ray Prudo, M.D. ×3 filings | March 30, 2020 | — | Initial filing | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.